Medical Research
International Thymic Malignancy Interest Group
SLEEPY HOLLOW, NY
Total revenue
$374K
Total expenses
$230K
Net assets
$312K
Grants received
$11K
4 grants
EIN
271652696
Tax year
2024
Mission
The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the disciplines. The academic journal Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies, has reopened More than 2000 patients are enrolled. The Biology Working Group has been created, .
Programs
2 programs
The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open to all researches and has data transfer agreements with all major institutions.
The 2024 Annual Meeting was held in Yokohama, Japan, in collaboration with the Japan Lung Cancer Society. The abstract book from the meeting is available in MEDIASTINUM.
Financials
FY 2024
Revenue
Expenses
People
5 listed
Dr Malgorzata Szolkowska
President
—
25 hrs/wk
Dr Paolo Mendogni
Secretary
—
25 hrs/wk
Dr Annemarie Fernandes Shepherd
Treasurer
—
25 hrs/wk
Dr Dirk Van Raemdonck
Vjce President
—
25 hrs/wk
Pam Bruce
Director
—
40 hrs/wk
Grants received
Showing 4 of 4
Funded by
$11K from 3 funders · 4 grants · 2019–2023
$5K · 1 grant · 2019
$5K · 1 grant · 2020
$825 · 2 grants · 2022–2023